Arbutus Biopharma Corp (ABUS)

Arbutus Biopharma Corp has filed 1,008 documents with the SEC available on Filing Fan. Browse annual reports (10-K), quarterly reports (10-Q), earnings releases (8-K), proxy statements, and more on Filing Fan. Filing Fan provides income statements, balance sheets, cash flow statements, and segment data parsed directly from EDGAR filings. All financial data is sourced from publicly available SEC regulatory filings.

Recent SEC filings

Form Date Description
8-K 2026-07-16 Termination of a Material Definitive Agreement; Departure/Appointment of Directors or Officers
4 2026-06-10 Statement of Changes in Beneficial Ownership
4 2026-06-10 Statement of Changes in Beneficial Ownership
S-8 2026-06-05 Employee Benefit Plan Registration
8-K 2026-05-27 Departure/Appointment of Directors or Officers; Submission of Matters to a Vote of Security Holders
SC 13G/A 2026-05-15 Beneficial Ownership Report (Passive, Amended)
8-K 2026-05-13 Results of Operations and Financial Condition; Financial Statements and Exhibits
10-Q 2026-05-13 Quarterly Report
SC 13D/A 2026-04-28 Beneficial Ownership Report (Amended)
8-K 2026-04-15 Other Events; Financial Statements and Exhibits